Skip to main content

Peer Review reports

From: Long-acting injectable antipsychotic (LAI) prescribing trends during COVID-19 restrictions in Canada: a retrospective observational study

Original Submission
21 Sep 2021 Submitted Original manuscript
17 Oct 2021 Reviewed Reviewer Report - Georgios Kotzalidis
22 Oct 2021 Reviewed Reviewer Report
14 Nov 2021 Author responded Author comments - Philip G Tibbo
Resubmission - Version 2
14 Nov 2021 Submitted Manuscript version 2
2 Dec 2021 Reviewed Reviewer Report - Georgios Kotzalidis
2 Dec 2021 Reviewed Reviewer Report
Resubmission - Version 3
Submitted Manuscript version 3
Publishing
7 Dec 2021 Editorially accepted
20 Dec 2021 Article published 10.1186/s12888-021-03646-9

You can find further information about peer review here.

Back to article page